CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 103 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $881,316 | +103.3% | 22,939 | +22.5% | 0.00% | 0.0% |
| Q1 2023 | $433,576 | -11.6% | 18,729 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $490,700 | +33.3% | 18,729 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $368,212 | +28.3% | 18,729 | +14.1% | 0.00% | 0.0% |
| Q2 2022 | $287,000 | +20.6% | 16,418 | +12.7% | 0.00% | – |
| Q1 2022 | $238,000 | +11.7% | 14,568 | +11.7% | 0.00% | – |
| Q4 2021 | $213,000 | +34.0% | 13,039 | +4.8% | 0.00% | – |
| Q3 2021 | $159,000 | -9.7% | 12,445 | 0.0% | 0.00% | – |
| Q2 2021 | $176,000 | -19.3% | 12,445 | -11.1% | 0.00% | – |
| Q1 2021 | $218,000 | -1.8% | 14,006 | 0.0% | 0.00% | – |
| Q4 2020 | $222,000 | – | 14,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |